Daud, Shaira I.

HRN: 28-21-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2025
CEFTRIAXONE 1G (VIAL)
12/05/2025
12/12/2025
IV DRIP
1.9g
Q24hours
PCAP-B; T/c Obstructive Jaundice
Checking Initial Appropriateness 
12/05/2025
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
12/05/2025
12/08/2025
PO
5ml
BID
Intestinal Parasitism
Checking Initial Appropriateness 
12/06/2025
CEFUROXIME 750MG (VIAL)
12/06/2025
12/13/2025
IV
630mg
Q8hours
PCAP-B
Checking Final Appropriateness 
12/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/06/2025
12/13/2025
IV
190mg
Q8
Hepa A
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: